why choose us

First received: July 09, 2023

Clinical Trial: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria

Study Status: Completed

Recruit Status: RECRUITING

Condition: Phenylketonuria

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria?a Randomized, Double-blind, Placebo-controlled, Parallel-group Clinical S

Brief Summary: This is a randomized, double-blind, placebo-controlled, parallel-group study.A total of 15 children with phenylketonuria(PKU) age 3 to 17 years will be randomized to two groups.Experimental group of 10 children will intervene engineered probiotics (CBT102-A) for 20 days and 5 children will intervene placebo.The goal of this study is to determine whether CBT102-A is an effective and safe treatment for PKU.

Read more